Connect with us

Hi, what are you looking for?


Vaccine Progress Boosts Pfizer Stock

Pfizer has released promising results in its vaccine development.

American pharmaceutical company Pfizer released new results this morning from its ongoing COVID-19 vaccine tests. In a clinical trial of 45 subjects, doses of 10, 30 or 100 micrograms of the experimental vaccine were administered, along with placebos for control purposes. After a 28 day period, 1 in 4 recipients of the 10 or 30 microgram doses developed neutralizing antibodies against the virus at levels approximately 1.8 to 2.8 times greater than those who recover from COVID-19 naturally.

“We are encouraged by the clinical data of BNT162b1, one of four mRNA constructs we are evaluating clinically, and for which we have positive, preliminary, topline findings,” Kathrin Jansen, head of Pfizer’s vaccine research and development, stated. “We are dedicated to develop potentially groundbreaking vaccines and medicines, and in the face of this global health crisis, we approach this goal with the utmost urgency.”

While this is minor progress, it is a step in the right direction, and the market has responded. Pfizer’s stock value jumped 4% on Wednesday morning after the results were posted, and despite recent flare-ups of the virus around the United States, the market is actually doing surprisingly well for itself. Around 2 million new jobs have managed to pop up around the country, beginning the process of recuperating the jobs lost in the last several months.

However, no matter how well the market is doing, investors are still concerned about the rising number of cases, especially in densely populated states like Texas and California.

“We’ve seen a huge move in the second quarter, and to be fair, it’s been driven by a lot of positivity,” Sevens Report founder Tom Essaye told Yahoo Finance on Tuesday. However, “the virus count is rising,” Essaye added. “That at a minimum is going to delay the economic reopening, and markets have to price that in a bit. And I think there is a bit more for it to turn sideways or further dip.”

You May Also Like


In the past year, Peloton, manufacturers of stationary exercise bicycles and treadmills, has been experiencing some severe financial difficulties. The company went through a...


While the ongoing supply chain problems affecting the global economy have had the expected effects, they’ve also had some decidedly unexpected effects. Specifically, many...


As gas prices continue to rise and consumer confidence drops, not to mention the ongoing war in Ukraine, the European economy is taking a...


As the environmental need for electric vehicles becomes more pressing, and the car-buying public becomes more eager for them, automotive manufacturers are getting ready...


This morning, Coinbase CEO Brian Armstrong sent a mass email out to his company informing everyone that, as stock and crypto prices slip and...


As Russia’s invasion of Ukraine continues, many global businesses have pulled their dealings out of Russian territories due to a mix of sanctions and...


In the last few weeks, fears have begun to surface of another potential recession striking the United States economy. Economists have been working to...


It’s no secret that the highs of the COVID-19 pandemic cost movie theater chain AMC an unprecedented amount of money. As people isolated at...